Search Results - fu-shin yu

3 Results

Sort By:

Topical treatment with TGFbeta3 to facilitate skin and corneal wound healing in diabetic patients

Background: Diabetes affects approximately 170 million people worldwide, including 20.8 million in the USA, and by 2030 these numbers are projected to double. Diabetics often experience slow or limited wound healing. Slow wound healing allows longer time for the development of infections and can contribute to the formation of bed sores and ulcers....

Published: 3/12/2018 | Inventor(s): Fu-Shin Yu

Keywords(s): Diabetes

Category(s): Medical, Biologicals, Biomedical, Drug Discovery, Metabolic disorders, Protein/peptides, Therapeutics, Life Science

Topical IL-1Ra (anakinra) in the form of gel to treat persistent diabetic skin and corneal wounds

BackgroundAnakinra (aka. Kineret) is a recombinant human IL-1Ra that was developed by Amgen. It is currently used to treat moderately to severely active rheumatoid arthritis, but also treats neonatal-onset multisystem inflammatory disease (NOMID). Anakinra is given as an IV dose and the drug is no longer under patent. The properties of Anakinra are...

Published: 5/25/2016 | Inventor(s): Fu-Shin Yu

Keywords(s):

Category(s): Biologicals, Drug Discovery, Pharmaceuticals, Therapeutics

Using Flagellin to Prevent and to Treat Inflammation Associated Gram Negative Bacterial Infection

This technology provides a new method for treating inflammatory diseases by using a Gram negative bacterial component that results in increased tolerance and immunity. Background & Unmet Need: Despite advances of modern medicine, bacterial sepsis remains one of the major threats to human health worldwide. In the US alone, it affects approximately...

Published: 5/18/2010 | Inventor(s): Fu-Shin Yu, Ashok Kumar, Jing Zhang, Linda Hazlett

Keywords(s): Anti-microbial, Asthma

Category(s): Therapeutics, Diseases, Life Science, Infectious disease